Terug
Dagbereik
€ 2,01
€ 2,10
52-Weeksbereik
€ 1,77
€ 5,81
Volume
2.378.298
50D / 200D Gem.
€ 2,35
/
€ 3,51
Vorige Slotkoers
€ 2,03
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 23,4 | 0,4 |
| P/B | 1,2 | 2,9 |
| ROE % | 4,5 | 3,7 |
| Net Margin % | 3,8 | 3,9 |
| Rev Growth 5Y % | 1,7 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 3,19
+53.4%
Low: € 2,75
High: € 4,00
Forward K/W
6,5
Forward WPA
€ 0,32
WPA Groei (sch.)
+0,0%
Omzet Sch.
760 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,00
€ 0,00 – € 0,00
|
910 M | 2 |
| FY2029 |
€ 0,89
€ 0,86 – € 0,91
|
930 M | 4 |
| FY2028 |
€ 0,45
€ 0,12 – € 0,84
|
870 M | 6 |
Belangrijkste Punten
Revenue grew 1,68% annually over 5 years — modest growth
Earnings grew 85,72% over the past year
ROE of 4,54% is below average
Debt/Equity of 0,10 — conservative balance sheet
Generating 164,38M in free cash flow
PEG of 0,31 suggests growth is underpriced
Groei
Revenue Growth (5Y)
1,68%
Revenue (1Y)0,57%
Earnings (1Y)85,72%
FCF Growth (3Y)41,13%
Kwaliteit
Return on Equity
4,54%
ROIC11,87%
Net Margin3,82%
Op. Margin13,42%
Veiligheid
Debt / Equity
0,10
Current Ratio2,61
Interest Coverage2,51
Waardering
P/E Ratio
23,42
P/B Ratio1,16
EV/EBITDA4,77
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,57% | Revenue Growth (3Y) | 3,06% |
| Earnings Growth (1Y) | 85,72% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1,68% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 796,85M | Net Income (TTM) | 30,44M |
| ROE | 4,54% | ROA | 2,17% |
| Gross Margin | 82,09% | Operating Margin | 13,42% |
| Net Margin | 3,82% | Free Cash Flow (TTM) | 164,38M |
| ROIC | 11,87% | FCF Growth (3Y) | 41,13% |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 2,61 |
| Interest Coverage | 2,51 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 23,42 | P/B Ratio | 1,16 |
| P/S Ratio | 0,89 | PEG Ratio | 0,31 |
| EV/EBITDA | 4,77 | Dividend Yield | 0,00% |
| Market Cap | 712,81M | Enterprise Value | 510,53M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 796,85M | 792,32M | 750,27M | 766,55M | 745,42M |
| Net Income | 30,44M | 16,39M | -8,87M | -32,83M | -25,25M |
| EPS (Diluted) | 0,09 | 0,04 | -0,02 | -0,08 | -0,06 |
| Gross Profit | 654,13M | 744,11M | 683,34M | 701,48M | 698,71M |
| Operating Income | 106,97M | 65,85M | -27,01M | 1,74M | 13,41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,40B | 1,39B | 1,59B | 1,60B | 1,61B |
| Total Liabilities | 787,80M | 663,41M | 826,84M | 789,80M | 775,95M |
| Shareholders' Equity | 616,26M | 724,66M | 761,96M | 814,83M | 831,68M |
| Total Debt | 59,54M | 543,39M | 711,07M | 717,02M | 702,33M |
| Cash & Equivalents | 261,82M | 448,35M | 672,30M | 757,17M | 941,11M |
| Current Assets | 643,10M | 659,26M | 872,79M | 919,69M | 1,09B |
| Current Liabilities | 246,00M | 123,90M | 122,56M | 76,32M | 81,11M |